Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Jul 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1615.25 [ +1.91% ]TCS 2530.70 [ +1.59% ]

Sensex32245.87
216.98 0.68%

Nifty9966.40
51.15 0.52%

Midcap15226.41
40.88 0.27%

Smallcap16035.76
43.13 0.27%



Astrazeneca Pharma India Ltd :

 965.00  -0.45 [-0.05%]

ISIN: INE203A01020  | NSE: ASTRAZEN |  Industry: Pharmaceuticals - Multinational  |  BSE Code: 506820  |  Add To Watchlist

Price Information
• Open 984.00
• High 1002.40
• Low 965.00
• Previous Close 965.45
• Shares Traded 303000
• 52 Wk High Price 1146.95
• 52 Wk High Date 24-08-2016
• 52 Wk Low Price 905.00
• 52 Wk Low Date 03-07-2017
• Face Value 2.00


Fundamentals
• Market Capital (Rs.cr) 2384.88
• EPS (Rs.)(TTM) 9.80
• P/E Ratio(TTM) 97.30
• Book Value (Rs.) 72.20
• Price to Book Value 13.21
• Equity (Rs.cr.) 5.00
• Traded Value (Rs.lac) 2.54


Corporate Actions
Ex-Date Purpose (Rs.)
2012-07-09 175% Dividend (3.5)


Index Names
BSE Small Cap
BSE-500
BSE HC


Related Companies
Stock Name Price
INDAGERES 8.10 -




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Mar, 2017 Mar, 2017 Mar, 2017
• Sales (Rs.cr) 110.95 526.31 526.31
• Net Profit (Rs.cr) -2.88 24.44 24.44
• Net Profit Var (%) - 368.00 368.00
• EPS (Rs) - 9.80 9.80
• P/E Ratio - 97.30 97.30
• Operating Profit Margin - 5.60 -
• CPS (Rs.) - - 16.10
• P/C Ratio - - 59.20
• Div% - - -

Announcements
29-05-2015 Astrazeneca Pharma India & Dr Reddys Laboratories enter into distribution agreement
16-05-2013 AstraZeneca Pharma India - Board to consider Dividend
04-11-2014 AstraZeneca Pharma India announces appointment of director
24-11-2014 AstraZeneca Pharma India announces resignation of director
07-12-2012 AstraZeneca Pharma India appoints additional director
11-11-2011 AstraZeneca Pharma India appoints director
31-08-2013 AstraZeneca Pharma India CFO resigns
03-05-2013 AstraZeneca Pharma India Director Resigns
15-06-2017 Astrazeneca Pharma India receives Import and Market permission for Asthma drug
12-05-2012 AstraZeneca Pharma India recommends dividend
27-07-2012 AstraZeneca Pharma India to announce Q1 results
01-09-2014 Astrazeneca Pharma India to hold AGM
10-06-2011 AstraZeneca Pharma India to hold board meeting
29-05-2017 AstraZeneca Pharma India to launch cancer drug - Osimertinib Tablet
22-07-2017 Astrazeneca Pharma India to launch Osimertinib Tablets (Tagrisso™)
19-10-2012 AstraZeneca Pharma to announce Q2 results
23-04-2011 AstraZeneca Pharma to consider dividend
02-08-2013 AstraZeneca Pharma to convene AGM On 20 August 2013
24-08-2016 AstraZeneca UK decides to terminate distribution agreement for Meronem
06-02-2016 Board of AstraZeneca Pharma India accepts resignation of director
03-12-2015 Board of Astrazeneca Pharma India decides to close API unit in Bangalore

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
21-07-2017 654 880 74.32 631405 849.56
20-07-2017 231 517 44.68 223528 502.97
19-07-2017 255 266 95.86 243258 254.22
18-07-2017 487 773 63.00 464842 744.12
17-07-2017 32330 32373 99.87 31040033 31078.20


Bulk Deals
Deal Date Client Name Type Qty Price
30-05-2013 CROSSEAS CAPITAL SERVICES PRIVATE LIMITED S 126180 845.63


Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  tata motor  •  incab industries  •  infr  •  first financial services  •  welspun corp
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech